We expect disappointing results in the first quarter will be balanced by higher-than-anticipated growth in the second half.

Shares of Novo Nordisk climbed nearly 7% on Wednesday after the company said sales of its obesity drug Wegovy are expected to ...

Novo Nordisk, which also makes Wegovy, fell victim to 'compounding' - a practice in the US that allows pharmacies to produce ...

Bio-Techne surpasses profit expectations with significant growth in its research products, leading to the announcement of a ...

WeightWatchers filed for Chapter 11 bankruptcy on Tuesday to eliminate $1.15 billion in debt, according to NPR. Parent company WW International Inc. said it has support from nearly 75% of debt holders ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...